{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T05:22:27Z","timestamp":1649136147242},"reference-count":21,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2019.7796","type":"journal-article","created":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T07:19:03Z","timestamp":1563520743000},"source":"Crossref","is-referenced-by-count":0,"title":["Ventricular tachycardia and heart failure in a patient of mid\u2011ventricular obstructive hypertrophic cardiomyopathy with apical aneurysm: A case report"],"prefix":"10.3892","author":[{"given":"Xin","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingbin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,7,19]]},"reference":[{"key":"key20200713100743_b1-etm-0-0-7796","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/S0140-6736(16)31321-6","article-title":"Hypertrophic obstructive cardiomyopathy","volume":"389","author":"Veselka","year":"2017","journal-title":"Lancet"},{"key":"key20200713100743_b2-etm-0-0-7796","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1161\/01.CIR.72.6.1148","article-title":"Has \u2018obstruction\u2019 hindered our understanding of hypertrophic cardiomyopathy?","volume":"72","author":"Criley","year":"1985","journal-title":"Circulation"},{"key":"key20200713100743_b3-etm-0-0-7796","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1001\/jama.287.10.1308","article-title":"Hypertrophic cardiomyopathy: A systematic review","volume":"287","author":"Maron","year":"2002","journal-title":"JAMA"},{"key":"key20200713100743_b4-etm-0-0-7796","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0033-0620(85)90024-6","article-title":"Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review","volume":"28","author":"Wigle","year":"1985","journal-title":"Prog Cardiovasc Dis"},{"key":"key20200713100743_b5-etm-0-0-7796","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1161\/CIRCULATIONAHA.108.781401","article-title":"Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy","volume":"118","author":"Maron","year":"2008","journal-title":"Circulation"},{"key":"key20200713100743_b6-etm-0-0-7796","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.jacc.2016.11.063","article-title":"Hypertrophic cardiomyopathy with left ventricular apical aneurysm: Implications for risk stratification and management","volume":"69","author":"Rowin","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"key20200713100743_b7-etm-0-0-7796","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"key20200713100743_b8-etm-0-0-7796","doi-asserted-by":"publisher","first-page":"e783","DOI":"10.1161\/CIR.0b013e318223e230","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"key20200713100743_b9-etm-0-0-7796","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1016\/j.jacc.2011.02.033","article-title":"Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy","volume":"57","author":"Minami","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"key20200713100743_b10-etm-0-0-7796","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1253\/circj.CJ-12-1561","article-title":"Clinical characteristics and natural history of hypertrophic cardiomyopathy with midventricular obstruction","volume":"77","author":"Efthimiadis","year":"2013","journal-title":"Circ J"},{"key":"key20200713100743_b11-etm-0-0-7796","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Authors\/Task Force members","year":"2014","journal-title":"Eur Heart J"},{"key":"key20200713100743_b12-etm-0-0-7796","doi-asserted-by":"publisher","first-page":"177","DOI":"10.15420\/aer.2015.4.3.177","article-title":"Long-term outcomes of ventricular tachycardia ablation in different types of structural heart disease","volume":"4","author":"Liang","year":"2015","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"key20200713100743_b13-etm-0-0-7796","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/hrt.77.5.481","article-title":"Hypertrophic cardiomyopathy with apical aneurysm: A case of catheter and surgical therapy of sustained monomorphic ventricular tachycardia","volume":"77","author":"Mantica","year":"1997","journal-title":"Heart"},{"key":"key20200713100743_b14-etm-0-0-7796","doi-asserted-by":"publisher","first-page":"e000072","DOI":"10.1161\/JAHA.113.000072","article-title":"Acute failure of catheter ablation for ventricular tachycardia due to structural heart disease: Causes and significance","volume":"2","author":"Tokuda","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"key20200713100743_b15-etm-0-0-7796","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jacc.2008.11.069","article-title":"The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: From idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy","volume":"54","author":"Maron","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"key20200713100743_b16-etm-0-0-7796","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2261-6-15","article-title":"Percutaneous septal ablation for left mid-ventricular obstructive hypertrophic cardiomyopathy: A case report","volume":"6","author":"Tengiz","year":"2006","journal-title":"BMC Cardiovasc Disord"},{"key":"key20200713100743_b17-etm-0-0-7796","doi-asserted-by":"publisher","first-page":"369","DOI":"10.21037\/acs.2017.05.09","article-title":"Alcohol septal ablation: In which patients and why?","volume":"6","author":"Spirito","year":"2017","journal-title":"Ann Cardiothorac Surg"},{"key":"key20200713100743_b18-etm-0-0-7796","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1053\/euje.2000.0032","article-title":"Percutaneous septal ablation for hypertrophic cardiomyopathy and mid-ventricular obstruction","volume":"1","author":"Seggewiss","year":"2000","journal-title":"Eur J Echocardiogr"},{"key":"key20200713100743_b19-etm-0-0-7796","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/joic.12331","article-title":"Effectiveness of alcohol septal ablation versus transaortic extended myectomy in hypertrophic cardiomyopathy with midventricular obstruction","volume":"29","author":"Yang","year":"2016","journal-title":"J Interv Cardiol"},{"key":"key20200713100743_b20-etm-0-0-7796","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1161\/CIRCULATIONAHA.117.030593","article-title":"Early outcomes of repair of left ventricular apical aneurysms in patients with hypertrophic cardiomyopathy","volume":"136","author":"Nguyen","year":"2017","journal-title":"Circulation"},{"key":"key20200713100743_b21-etm-0-0-7796","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/S0140-6736(06)68074-4","article-title":"Controversies in ventricular remodelling","volume":"367","author":"Opie","year":"2006","journal-title":"Lancet"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T09:07:53Z","timestamp":1594631273000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2019.7796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,19]]},"references-count":21,"URL":"https:\/\/doi.org\/10.3892\/etm.2019.7796","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,19]]}}}